
Abstract Background: Conotoxins of the O1 gene superfamily are valuable ion channel research tools and potential drug candidates because they selectively and efficiently target sodium, potassium, or calcium channels. Among them, the calcium channel-targeting ω-conotoxin MVIIA (ziconotide) was approved by the FDA in 2004 to treat intractable pain, whereas several Nav1.8-targeting μO-conotoxins have undergone preclinical investigation as potential treatments for neuropathic pain. In this study, TxO6, an O1 gene superfamily conotoxin with sequence similarity to μO-conotoxins, was synthesized, and its physiological targets were investigated. Methods: TxO6, containing three disulfide bonds, was synthesized using solid-phase peptide synthesis, purified by HPLC, and characterized by mass spectrometry. The effects of synthetic TxO6 on sodium, potassium and calcium currents were evaluated using patch-clamp recordings in acutely isolated rat dorsal root ganglion (DRG) neurons. The effects of TxO6 on four human sodium and potassium channel subtypes expressed in HEK293 or ND7/23 cells were also evaluated. Results: TxO6 (1 μM) had no apparent effect on the current-voltage (I-V) relationships, activation, inactivation, or recovery of sodium currents. TxO6 (1 μM) also had no apparent effect on the I-V relationships of calcium currents. In contrast, TxO6 inhibited rat DRG potassium currents in a concentration-dependent manner, with an IC₅₀ of 0.89 ± 0.24 μM. Regarding specific subtypes, TxO6 (1 μM) had no apparent effect on hNav1.7 currents but appeared to slightly delay the inactivation of hNav1.8 currents. Furthermore, TxO6 (1 μM) inhibited hKv1.1 and hKv7.1 currents by 4.75% ± 0.65% and 11.20% ± 1.87%, respectively. Conclusion: These results indicate that TxO6 preferentially inhibits native potassium currents in rat DRG neurons and may be a candidate for further investigation as a pharmacological probe for potassium channels.
Abstract Background: Antibiotic resistance is a major global health challenge driven by the declining availability of effective antimicrobials. Antimicrobial peptides (AMPs) from venomous organisms are promising alternatives because of their broad-spectrum activity and low propensity for resistance development. Chihuahuanus coahuilae, an endemic scorpion from northern Mexico, produces a venom rich in bioactive peptides with potential therapeutic applications. Methods: Venom gland transcriptomic analysis identified four novel AMP sequences, which were chemically synthesized and evaluated through structural, antimicrobial, hemolytic, cytotoxicity, and immunological assays. Antibacterial activity was assessed against clinically relevant bacterial strains, including a multidrug-resistant Acinetobacter baumannii isolate. Hemolysis was evaluated using human erythrocytes, and immunocompatibility was determined in peripheral blood mononuclear cells (PBMCs) by measuring T-cell viability and cytokine production. Results: The peptides exhibited bactericidal activity against Enterococcus faecalis (EC50 = 86.5-157.3 µM), Escherichia coli (EC50 = 22.7-69.6 µM), and multidrug resistant A. baumannii (EC50 = 11.4-97.7 µM). Hemolytic activity remained below 10% at concentrations up to 20 µM. T-cell viability exceeded 85% at antimicrobial EC50 concentrations, indicating limited cytotoxicity. Cytokine profiling revealed no significant induction of TNF-α or IL-6 at therapeutically relevant concentrations, supporting a favorable immunocompatibility profile. Conclusion: These findings identify four novel venom-derived AMPs with potent antibacterial activity, low hemolytic and cytotoxic effects, and minimal immunostimulatory properties. Their combined antimicrobial efficacy and favorable safety profile support further preclinical development as candidates for treating multidrug-resistant bacterial infections.
Abstract Background: Tityus championi is a species endemic to the southern Talamanca Mountain Range, along the border region between Costa Rica and Panama, and has been associated with severe clinical cases. Despite its medical relevance, the composition of its venom remains poorly studied. The present study aimed to characterize the proteomic composition of T. championi venom, identify its main toxin families, and recombinantly produce one of its most abundant and lethal toxins for potential use in antivenom development. Methods: Venom composition was analyzed by tandem mass spectrometry (MS/MS), enabling the identification of venom proteins. Subsequently, one of its primary lethal toxins (Tcham27) was identified and recombinantly expressed. Results: Proteomic analysis revealed that the most abundant family in the venom corresponded to metalloproteases, with 43 protein groups (17% of the total identifications), which are associated with processes such as hemorrhage, edema, inflammation, hypotension, and necrosis. CIIMET family toxins comprised 27 protein groups (11%). Among ion channel-acting toxins, 18 protein groups (7%) corresponded to sodium channel toxins and 14 (6%) to potassium channel toxins, homologous to components from geographically proximate species such as Tityus discrepans, Tityus cf. asthenes, and Tityus jaimei. Other relevant families included cysteine-rich secretory proteins (CRISPs; 6 proteins, 3%), serine proteases (5 proteins, 2%), and lectins (5 proteins, 2%). In addition, low-abundance components such as insulin-like growth factors, nucleotide pyrophosphatases, hyaluronidase, α-amylase, lipolysis-activated toxins, and chitinase were detected, contributing to the functional diversity of the venom. Conclusions: Proteomic characterization of T. championi venom demonstrates that metalloproteases constitute a major protein family alongside neurotoxins. Recombinant production of its most abundant toxic peptide, which is identical to toxins in the venom of geographically proximate Tityus species, provides a key tool for developing specific antivenoms.
Abstract Background: Snakebite envenomation caused by G. brevicaudus and D. acutus frequently presents with overlapping hemorrhagic and coagulopathic manifestations in clinical settings. However, whether these similarities reflect convergent venom phenotypes remains unclear. Methods: We performed an integrated comparative analysis combining nano-LC-MS/MS proteomics with multi-target functional assays to systematically evaluate venom composition and biological activities. Proteomic profiling was used to characterize toxin family abundance, while enzymatic, cytotoxic, hemolytic, and cell signaling assays were conducted to assess functional effects. Results: Proteomic analysis revealed that both venoms are predominantly composed of hemotoxic toxin families, including snake venom metalloproteinases (SVMP), snake venom serine proteases (SVSP), C-type lectin-like proteins (CTLP), and phospholipase A₂ (PLA₂), with broadly comparable relative abundances. Functional assays demonstrated similar concentration-dependent patterns in proteolytic, PLA₂, thrombin-like, and fibrinolytic activities, with no statistically significant interspecific differences. Both venoms also induced comparable cytotoxic effects across mammalian cell lines, while exhibiting limited hemolytic activity and minimal modulation of Ca²⁺ signaling and nitric oxide production. Conclusions: These findings demonstrate that G. brevicaudus and D. acutus venoms share a convergent hemotoxic functional architecture characterized by consistent enzymatic activities and similar cytotoxic profiles. This functional convergence provides a mechanistic basis for clinically overlapping hemorrhagic and coagulopathic manifestations observed in envenomation cases. The results further emphasize the importance of function-oriented venom profiling and suggest potential implications for antivenom cross-reactivity and therapeutic development.
ABSTRACT Background: The increasing incidence of Candida glabrata complex infections in hospitalized patients and their association with high mortality rates prompted the determination of cryptic species among clinical isolates from a tertiary hospital and the evaluation of their susceptibility profiles to commonly prescribed antifungal agents. Methods: This study evaluated 80 C. glabrata isolates obtained from patients admitted to a Brazilian public tertiary hospital. The isolates were recovered from different clinical specimens, predominantly urine and blood, across various medical units. Results: MALDI-TOF MS analysis revealed that all isolates were Candida glabrata sensu stricto. Minimum inhibitory concentrations (MICs), determined via broth microdilution and according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines, showed high susceptibility to amphotericin B (AmB), voriconazole (VRC), and echinocandins (ECNs) [caspofungin (CSF), anidulafungin (ANF), and micafungin (MCF)], as well as uniform susceptibility within the "I" category (susceptible, increased exposure) to fluconazole (FLC). Comparisons of resistance profiles revealed higher prevalences of resistance to AmB and VRC than to ECNs, both overall and in urine isolates, with a similar trend observed in blood isolates. Comparative analysis with reference EUCAST C. glabrata data highlighted higher localized MIC values for AmB, ANF, and MCF, lower MICs for FLC, and equivalent distributions for VRC. Conclusion: All recovered isolates were confirmed as Candida glabrata sensu stricto and exhibited different susceptibility profiles from reference EUCAST isolates. These findings establish a strong regional baseline, serving as a useful guide for monitoring therapeutic measures and supporting antimicrobial stewardship.